Medical Biotechnology

Flemish researchers launch OPENPichia, an industrial open access yeast system for the production of proteins

Flemish researchers launch OPENPichia, an industrial open access yeast system for the production of proteins

The system has applications in the production of medicines, and edible and industrial proteins, offering a cheaper and qualitative alternative to existing commercial variants

March 5, 2024

VIB and Ghent University develop new mRNA vaccines against bacterial infections

VIB and Ghent University develop new mRNA vaccines against bacterial infections

Vaccine consortium Baxerna doubles down on antimicrobial resistance

April 25, 2023

mRNA vaccines against bacteria: Listeria shows the way

mRNA vaccines against bacteria: Listeria shows the way

The development of a Listeria vaccine opens a route to producing mRNA vaccines against other bacterial infections.

October 17, 2022

All in the game: VIB-UGent researchers enlist virtual space explorers to improve disease diagnostics

All in the game: VIB-UGent researchers enlist virtual space explorers to improve disease diagnostics

By harnessing the power of thousands of gamers, the team of Prof. Lennart Martens (VIB-UGent Center for Medical Biotechnology), with colleagues of Dhaenes lab of the Faculty of Pharmaceutical Sciences at Ghent University, intends to improve the analysis of mass spectrometry data drastically. In turn, this may advance disease diagnostics.

August 15, 2022

Digging for brain disease biomarkers with innovative proteomics

Digging for brain disease biomarkers with innovative proteomics

Two VIB research teams join forces to look for biomarkers in blood and cerebrospinal fluid samples of people living with frontotemporal degeneration.

December 23, 2021

About VIB

VIB’s core mission is to generate disruptive insights in the molecular underpinning of life and to translate these actively into impactful innovations for patients and society. VIB is an independent research institute where some 1,800 top scientists from Belgium and abroad conduct pioneering basic research. As such, they are pushing the boundaries of what we know about molecular mechanisms and how they rule living organisms such as human beings, animals, plants, and microorganisms. Based on a close partnership with five Flemish universities – Ghent University, KU Leuven, University of Antwerp, Vrije Universiteit Brussel, and Hasselt University – and supported by a solid funding program, VIB unites the expertise of all its collaborators and research groups in a single institute. VIB’s technology transfer activities translate research results into concrete benefits for society such as new diagnostics and therapies and agricultural innovations. These applications are often developed by young start-ups from VIB or through collaborations with other companies. This also leads to additional employment and bridges the gap between scientific research and entrepreneurship. VIB also engages actively in the public debate on biotechnology by developing and disseminating a wide range of science-based information. 

More info can be found on www.vib.be.

Contact